Contents

Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 5 - Number 5

Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects

, 5(5): 355 - 375

Antonis S. Manolis, Stylianos Tzeis, Kostas Triantafyllou, John Michaelidis, Ioannis Pyrros, Nikolaos Sakellaris, Athanasios Kranidis and Helen Melita


DOI: 10.2174/156800605774370326




Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective

, 5(5): 377 - 386

Rupal Dumasia, Kim A. Eagle, Eva Kline-Rogers, Niquole May, Leslie Cho and Debabrata Mukherjee


DOI: 10.2174/156800605774370362




The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation

, 5(5): 387 - 403

Polychronis Dilaveris, Georgios Giannopoulos, Andreas Synetos and Christodoulos Stefanadis


DOI: 10.2174/156800605774370317




Will this be the End of the Anticoagulation Clinic for Patients with Atrial Fibrillation?

, 5(5): 405 - 408

Andrew R.J. Mitchell


DOI: 10.2174/156800605774370344




Drug Therapy in Brugada Syndrome

, 5(5): 409 - 417

Manlio F. Marquez, Gabriel Salica, Antonio G. Hermosillo, Gustavo Pastelin and Manuel Cardenas


DOI: 10.2174/156800605774370353




An Old Drug with a New Purpose: Cardiovascular Actions of Acetaminophen (Paracetamol)

, 5(5): 419 - 429

Norell M. Spiler, Tyler H. Rork and Gary F. Merrill


DOI: 10.2174/156800605774370335




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science